CHRISTOPHER S HENNEY Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for CHRISTOPHER S HENNEY.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of CHRISTOPHER S HENNEY. CHRISTOPHER S HENNEY is a Director in BIO-TECHNE Corp ($TECH) and a Chairman of the Board in DENDREON CORP ($DNDN) and a Director in Cyclacel Pharmaceuticals, Inc. ($CYCC) and a in Anthera Pharmaceuticals Inc ($ANTH) and a Director in Oncothyreon Inc. ($ONTY) and a Interim CEO and President in Oncothyreon Inc. ($ONTY) and a Director in Prothena Corp plc ($PRTA).
Address: 3005 FIRST AVENUE SEATTLE 98121 WA
Companies in which CHRISTOPHER S HENNEY is an Insider
Anthera Pharmaceuticals Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of CHRISTOPHER S HENNEY:
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jan 09 2018
$ANTH Market Capitalization: $23.84M
$ANTH Previous Close: $0.59
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
BIO-TECHNE Corp
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of CHRISTOPHER S HENNEY: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Nov 03 2003
$TECH Market Capitalization: $3.73B
$TECH Previous Close: $101.18
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Cascadian Therapeutics, Inc.
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of CHRISTOPHER S HENNEY: Interim CEO and President, Director
Holdings: 0 shares
Latest Transaction: Mar 13 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Cyclacel Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of CHRISTOPHER S HENNEY: Director
Holdings: 0 shares
Latest Transaction: Jun 29 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
DENDREON CORP
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of CHRISTOPHER S HENNEY: Chairman of the Board
Holdings: 346,577 shares
Latest Transaction: Jul 30 2003
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
PROTHENA CORP PUBLIC LTD CO
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of CHRISTOPHER S HENNEY: Director
Holdings: 900 shares
Current Value: $44,550
Latest Transaction: May 22 2020
$PRTA Market Capitalization: $1.71B
$PRTA Previous Close: $49.50
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of CHRISTOPHER S HENNEY
Sentiment: All, ANTH, TECH, CASC, CYCC, DNDN, PRTA
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 29 2020 | CYCC | Cyclacel Pharmaceu ... | HENNEY CHRISTOPHER S | Director | Option Exercise | A | 4.70 | 5,200 | 24,440 | 5,200 | |
| May 22 2020 | PRTA | Prothena Corp plc | HENNEY CHRISTOPHER S | Director | Option Exercise | A | 11.33 | 17,500 | 198,275 | 17,500 | |
| May 31 2019 | CYCC | Cyclacel Pharmaceu ... | HENNEY CHRISTOPHER S | Director | Option Exercise | A | 0.64 | 18,750 | 12,000 | 18,750 | |
| May 31 2019 | CYCC | Cyclacel Pharmaceu ... | HENNEY CHRISTOPHER S | Director | Option Exercise | A | 0.64 | 18,750 | 12,000 | 18,750 | |
| May 24 2019 | PRTA | Prothena Corp plc | HENNEY CHRISTOPHER S | Director | Option Exercise | A | 9.23 | 17,500 | 161,525 | 17,500 | |
| Jun 04 2018 | CYCC | Cyclacel Pharmaceu ... | HENNEY CHRISTOPHER S | Director | Option Exercise | A | 1.42 | 8,576 | 12,178 | 8,576 | |
| May 18 2018 | PRTA | Prothena Corp plc | HENNEY CHRISTOPHER S | Director | Option Exercise | A | 16.43 | 12,000 | 197,160 | 12,000 |